EUVIMEDEUVIMED entdecken
Crossref

A family of Bayesian prognostic and predictive covariate-adjusted response-adaptive randomization designs

Xinyi Pei iD, Yujie Zhao, Jun Yu, Li Wang, Hongjian Zhu iD

Statistical Methods in Medical Research · 2025

DOI: 10.1177/09622802251335150 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Statistical Methods in Medical Research, 2025. Verfasst von Xinyi Pei und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Statistics, Purdue University, West Lafayette, IN, USA. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Research Design. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prudent use of covariates to enhance the efficiency and ethics of clinical trials has garnered significant attention, particularly following the FDA’s 2023 guidance on adjusting for covariates. This article introduces a Bayesian covariate-adjusted response-adaptive design aimed at distinguishing between prognostic and predictive covariates during randomization and analysis. The proposed design allocates more patients to the superior treatment based on predictive covariates while maintaining balance across prognostic covariate levels, without sacrificing the power to detect treatment effects. Predictive covariates, which identify patients more likely to benefit from a treatment, and prognostic covariates, which predict overall clinical outcomes, are crucial for personalized medicine and ethical rigor in clinical trials. The Bayesian covariate-adjusted response-adaptive design leverages these covariates to enhance precision and ensure balanced comparison groups, addressing patient heterogeneity and improving treatment efficacy. Our approach builds on the foundation of response-adaptive randomization designs, incorporating Bayesian methodologies to manage the complexities of adaptive designs and control the Type I error rate. Comprehensive numerical studies demonstrate the advantages of our design in achieving ethical, efficient, and balancing goals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Randomized Controlled Trials as TopicResearch DesignBayes TheoremHumansPrognosisRandom AllocationModels, Statistical

Stichwörter der Autor:innen

Adaptive randomizationclinical trialsclipping of probabilitiesefficiency and ethicsprecision medicine

Autor:innen und Institutionen

  • Department of Statistics, Purdue University, West Lafayette, IN, USA.
  • Data and Statistical Sciences, AbbVie Inc., North Chicago, IL, USA.
  • Medical Affairs and Health Technology Assessment Statistics, AbbVie Inc., Sugar Land, TX, USA.

ORCID-Profile: Xinyi Pei, Hongjian Zhu

Zitieren

APA

Pei, X., Zhao, Y., Yu, J., Wang, L., & Zhu, H. (2025). A family of Bayesian prognostic and predictive covariate-adjusted response-adaptive randomization designs. Statistical Methods in Medical Research. https://doi.org/10.1177/09622802251335150

Vancouver

Pei X, Zhao Y, Yu J, Wang L, Zhu H. A family of Bayesian prognostic and predictive covariate-adjusted response-adaptive randomization designs. Statistical Methods in Medical Research. 2025. doi:10.1177/09622802251335150

BibTeX
@article{Pei2025,
  author = {Pei, Xinyi and Zhao, Yujie and Yu, Jun and Wang, Li and Zhu, Hongjian},
  title = {A family of Bayesian prognostic and predictive covariate-adjusted response-adaptive randomization designs},
  journal = {Statistical Methods in Medical Research},
  year = {2025},
  doi = {10.1177/09622802251335150}
}
Kostenlos starten →